Previous close | 17.70 |
Open | 17.70 |
Bid | 16.35 |
Ask | 17.20 |
Strike | 30.00 |
Expiry date | 2025-01-17 |
Day's range | 17.70 - 17.70 |
Contract range | N/A |
Volume | |
Open interest | 87 |
We recently compiled a list of the 7 Best Debt Free Stocks To Buy. In this article, we are going to take a look at where Cassava Sciences Inc (NASDAQ:SAVA) stands against the other debt free stocks. Debt has always been the fuel driving many companies in the equity markets. Access to cheap capital when […]
With the business potentially at an important milestone, we thought we'd take a closer look at Cassava Sciences, Inc.'s...
$207.3 Million in Cash and Cash Equivalents at June 30, 2024.Company in Advanced Discussions to Resolve SEC Investigation. $40 Million Estimated Loss Contingency Recorded in Q2 for Resolution.Conference Webcast Scheduled for Today at 8:30AM ET. AUSTIN, Texas, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on a novel treatment for Alzheimer’s disease, today reported financial results for the second quarter ended June 30, 2024. Net income w